Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETON Eton Pharmaceuticals, Inc.

Post-Mkt 10-30 19:00:50 EDT

52.18

-1.49

-2.78%

盘后53.75

+1.57+3.01%

18:46 EDT

High53.62	Low51.89	Vol335.71K
Open53.33	D1 Closing53.67	Amplitude3.22%
Mkt Cap1.49B	Tradable Cap1.16B	Total Shares28.58M
T/O17.60M	T/O Rate1.51%	Tradable Shares22.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":52.18,"timestamp":1793390400000,"preClose":53.67,"halted":0,"volume":335710,"hourTrading":{"tag":"盘后","latestPrice":53.75,"preClose":52.18,"latestTime":"18:46 EDT","volume":11929,"amount":623000.423016,"timestamp":1793400366555,"change":1.57,"changeRate":0.030088,"amplitude":0.033752},"delay":0,"changeRate":-0.027762250791876317,"floatShares":22304300,"shares":28583135,"eps":0.39,"marketStatus":"Post-Mkt","change":-1.49,"latestTime":"10-30 19:00:50 EDT","open":53.33,"high":53.615,"low":51.886,"amount":17597158.15256,"amplitude":0.032215,"askPrice":55,"askSize":10,"bidPrice":50,"bidSize":3,"shortable":3,"etf":0,"ttmEps":0.39,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793404800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":53.67,"preHourTrading":{"tag":"盘前","latestPrice":54.29,"preClose":53.67,"latestTime":"09:17 EDT","volume":637,"amount":34205.245711,"timestamp":1793366253501,"change":0.62,"changeRate":0.011552,"amplitude":0.028513},"postHourTrading":{"tag":"盘后","latestPrice":53.75,"preClose":52.18,"latestTime":"18:46 EDT","volume":11929,"amount":623000.423016,"timestamp":1793400366555,"change":1.57,"changeRate":0.030088,"amplitude":0.033752},"volumeRatio":0.948636,"impliedVol":0.7812,"impliedVolPercentile":0.753},"requestUrl":"/m/hq/s/ETON/wiki","defaultTab":"wiki","newsList":[{"id":"1113504255","title":"Earning Preview: Eton Pharmaceuticals, Inc. revenue is expected to increase by 89.82%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1113504255","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1113504255?lang=en_us&edition=fundamental","pubTime":"2026-10-30 01:44","pubTimestamp":1793295853,"startTime":"0","endTime":"0","summary":"Abstract Eton Pharmaceuticals, Inc. will report quarterly results on November 5, 2026, Post-Mkt; investors are watching for whether revenue accelerates toward guidance, margins hold near recent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Eton Pharmaceuticals, Inc. revenue is expected to increase by 89.82%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679247047","title":"Eton Pharmaceuticals to Report Third-Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2679247047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679247047?lang=en_us&edition=fundamental","pubTime":"2026-10-29 18:54","pubTimestamp":1793271276,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals to Report Third-Quarter Financial ResultsEton Pharmaceuticals will report third-quarter 2026 financial results on Nov. 5, 2026.Management will host a conference call and live webc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL9TzWbc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","LU2210150020.SGD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU2095319765.USD","ETON","LU0314104364.USD","IE00B3QW5Z07.USD","BK4007","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","BCDF","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014013.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675329117","title":"US Stocks on the MOVE-Netflix, Coinbase Global, Accenture","url":"https://stock-news.laohu8.com/highlight/detail?id=2675329117","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675329117?lang=en_us&edition=fundamental","pubTime":"2026-10-15 01:43","pubTimestamp":1791999817,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Netflix, Coinbase Global, AccentureWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nL4N4601QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADX","VERU","ZBAO","VSTM","EAT","AKAM","YRD","GFS","FAST","SKYD","S","HOOD","ARWR","CANG","ACN","CBOE","IONL","AQST","NFG","TGL","ABBV","CIFR","ETON","FLNC","BLK","GME","HL","MRK","SIVR","BAC","ACI","FLEX","BSP","WY","DELL","LQDA","IONQ","ENVX","RIOT","AMTD","EVTL","CABO","LLY","AEP","ILDR","AEHL","COIN","DOCN","NFLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675329150","title":"Eton Pharmaceuticals Price Target Maintained with a $70.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2675329150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675329150?lang=en_us&edition=fundamental","pubTime":"2026-10-15 01:38","pubTimestamp":1791999480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETON/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675914346","title":"Eton Pharmaceuticals - Entered into Supply Agreement with Aquestive; Agreement for Libervant Has Initial Term of 20 Years - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2675914346","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675914346?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:16","pubTimestamp":1791976589,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN4601BD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675834698","title":"Eton Pharmaceuticals - to Pay Aquestive Royalties at Mid-Teens Percentage Rate on Libervant Sales - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2675834698","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675834698?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:16","pubTimestamp":1791976589,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN4601BD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675346604","title":"Eton Pharmaceuticals - to Pay Aquestive up to $47.50 Mln in Milestone Payments - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2675346604","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675346604?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:16","pubTimestamp":1791976589,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN4601BD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675346601","title":"Eton Pharmaceuticals - Under Agreement, Co Pays Aquestive Upfront License Fee of $10 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2675346601","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675346601?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:16","pubTimestamp":1791976589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN4601BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675469863","title":"Eton Pharmaceuticals Licenses US Rights to Aquestive's Epilepsy Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2675469863","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675469863?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:15","pubTimestamp":1791976509,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals  said Wednesday that it has signed an exclusive US licensing and supply agreement with Aquestive Therapeutics  for Aquestive's Libervant buccal film, a treatment for seizure clusters in patients with epilepsy.Eton said it expects the product to be commercially available in April.Eton said the deal expands its rare disease portfolio into neurology, with Aquestive supplying the product and Eton  handling US commercialization and drawing on its specialty drug sales and patient support capabilities.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AQST","BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675345790","title":"Eton and Aquestive announce license and supply agreement for Libervant","url":"https://stock-news.laohu8.com/highlight/detail?id=2675345790","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675345790?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:55","pubTimestamp":1791975348,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (ETON) and Aquestive Therapeutics (AQST) announced that they have entered into an exclusive license agreement and a supply agr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eton-and-aquestive-announce-license-and-supply-agreement-for-libervant-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eton-and-aquestive-announce-license-and-supply-agreement-for-libervant-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AQST","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675574345","title":"Eton Pharmaceuticals - Libervant Commercial Launch Anticipated in April 2027, Subject to Final FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2675574345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675574345?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:50","pubTimestamp":1791975000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA437PCB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455793","title":"Eton Pharmaceuticals - Type 9 Nda Under FDA Review to Add Ages 6-11 to Libervant Label; Pdufa Date March 29, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675455793?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:50","pubTimestamp":1791975000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA437PCB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455063","title":"Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for Libervant® (Diazepam) Buccal Film","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675455063?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:50","pubTimestamp":1791975000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA437PCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675434550","title":"Eton Pharmaceuticals - Libervant Has Orphan Drug Designation and Patent Protection Extending into 2038","url":"https://stock-news.laohu8.com/highlight/detail?id=2675434550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675434550?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:50","pubTimestamp":1791975000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA437PCB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675345577","title":"Eton Pharmaceuticals - Libervant Expected to be Eligible for Full Approval in Patients 12+ After Jan 10, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675345577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675345577?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:50","pubTimestamp":1791975000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA437PCB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673109779","title":"Is Impavido Launch Altering The Investment Case For Eton Pharmaceuticals (ETON)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109779","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673109779?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:26","pubTimestamp":1791368768,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals recently launched IMPAVIDO (miltefosine) capsules in the US for multiple forms of leishmaniasis in eligible patients 12 years and older who weigh at least 30 kg.\nThe IMPAVIDO release adds a commercially available antileishmanial therapy to Eton Pharmaceuticals' rare disease franchise and expands its portfolio into a highly specialized infectious disease segment with complex safety and monitoring needs.\nThe focus now turns to how Eton Pharmaceuticals' rare disease...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-impavido-launch-altering-the-investment-case-for-eton-pha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-impavido-launch-altering-the-investment-case-for-eton-pha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065988","title":"Eton Pharma Chief Business Officer David Krempa Sells 4,166 Common Shares for $229,405.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065988","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065988?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:50","pubTimestamp":1791319802,"startTime":"0","endTime":"0","summary":"Eton Pharma Chief Business Officer David Krempa sells 4,166 common shares for $229,405.56Eton Pharmaceuticals Chief Business Officer David Krempa sold 4,166 common shares on Oct. 6, 2026 at USD 55.066","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL5QFG6d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma Chief Business Officer David Krempa Sells 4,166 Common Shares for $229,405.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672678126","title":"Eton Pharmaceuticals Down over 15%, on Pace for Largest Percent Decrease Since November 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2672678126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672678126?lang=en_us&edition=fundamental","pubTime":"2026-10-01 02:39","pubTimestamp":1790793540,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.  is currently at $50.20, down $8.99 or 15.19%--Would be lowest close since Aug. 13, 2026, when it closed at $40.80--On pace for largest percent decrease since Nov. 10, 2023, when it fell 15.23%--Snaps a two day winning streak--Down 16.94% month-to-date--Up 196.87% year-to-date--Down 22.09% from its all-time closing high of $64.43 on Aug. 24, 2026--Up 147.78% from 52 weeks ago , when it closed at $20.26--Down 22.09% from its 52-week closing high of $64.43 on Aug. 24, 2026--Up 249.83% from its 52-week closing low of $14.35 on Feb. 5, 2026--Traded as low as $50.12; lowest intraday level since Aug. 13, 2026, when it hit $40.66--Down 15.32% at today's intraday low; largest intraday percent decrease since March 18, 2025, when it fell as much as 16.74%All data as of 2:37:59 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234379","title":"Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234379","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234379?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:37","pubTimestamp":1790595423,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals  said Monday that it launched Impavido  capsules to treat leishmaniasis, a parasitic disease, in adults and adolescents aged 12 and older weighing at least 30 kilograms.The company said its Eton Cares program will provide patient support services, including $0 co-pay for eligible commercially insured patients, while it works to expand hospital availability through a consignment inventory program.Eton also said it will offer an emergency access pathway for urgent patient needs through Anovo Specialty Pharmacy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239912","title":"Eton Pharmaceuticals - Holds Exclusive Commercialization Rights for Impavido in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239912?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA82RRT6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":0.073},{"period":"1month","weight":-0.0933},{"period":"3month","weight":0.1562},{"period":"6month","weight":0.8571},{"period":"1year","weight":1.9312},{"period":"ytd","weight":2.1739}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0068},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0676},{"period":"1year","weight":0.1192},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.049574},{"month":2,"riseRate":0.5,"avgChangeRate":0.007501},{"month":3,"riseRate":0.5,"avgChangeRate":0.000763},{"month":4,"riseRate":0.375,"avgChangeRate":0.041311},{"month":5,"riseRate":0.625,"avgChangeRate":0.018979},{"month":6,"riseRate":0.25,"avgChangeRate":-0.044284},{"month":7,"riseRate":0.5,"avgChangeRate":0.004018},{"month":8,"riseRate":0.75,"avgChangeRate":0.169767},{"month":9,"riseRate":0.5,"avgChangeRate":0.04526},{"month":10,"riseRate":0.625,"avgChangeRate":0.064523},{"month":11,"riseRate":0.571429,"avgChangeRate":0.051311},{"month":12,"riseRate":0.625,"avgChangeRate":0.051914}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}